136 related articles for article (PubMed ID: 15183121)
1. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells.
Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121
[TBL] [Abstract][Full Text] [Related]
2. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
3. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF.
Csapó Z; Sasvári-Székely M; Spasokoukotskaja T; Staub M
Acta Biochim Pol; 2001; 48(1):251-6. PubMed ID: 11440177
[TBL] [Abstract][Full Text] [Related]
5. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
[TBL] [Abstract][Full Text] [Related]
6. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Hapke DM; Stegmann AP; Mitchell BS
Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia.
Beck FW; Eilender DS; Dandashi MH; Siddiq F; Snell DC; Godmere MA; Al-Katib AM; Mohammad RM
Int J Mol Med; 2004 Jul; 14(1):113-9. PubMed ID: 15202025
[TBL] [Abstract][Full Text] [Related]
9. Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2'-deoxyadenosine (Cladribine) in human lymphocytes.
Sasvári-Székely M; Spasokoukotskaja T; Szóke M; Csapó Z; Turi A; Szántó I; Eriksson S; Staub M
Biochem Pharmacol; 1998 Nov; 56(9):1175-9. PubMed ID: 9802328
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3'-kinase is associated with a serine kinase that is activated by okadaic acid.
Cengel KA; Godbout JP; Freund GG
Biochem Biophys Res Commun; 1998 Jan; 242(3):513-7. PubMed ID: 9464247
[TBL] [Abstract][Full Text] [Related]
11. Identification and H2O2 sensitivity of the major constitutive MAPK phosphatase from rat brain.
Foley TD; Armstrong JJ; Kupchak BR
Biochem Biophys Res Commun; 2004 Mar; 315(3):568-74. PubMed ID: 14975738
[TBL] [Abstract][Full Text] [Related]
12. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
[TBL] [Abstract][Full Text] [Related]
13. Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity.
Spasokoukotskaja T; Sasvári-Székely M; Keszler G; Albertioni F; Eriksson S; Staub M
Eur J Cancer; 1999 Dec; 35(13):1862-7. PubMed ID: 10674004
[TBL] [Abstract][Full Text] [Related]
14. Activation of deoxycytidine kinase by various nucleoside analogues.
Spasokoukotskaja T; Sasvári-Székely M; Hullán L; Albertioni F; Eriksson S; Staub M
Adv Exp Med Biol; 1998; 431():641-5. PubMed ID: 9598144
[TBL] [Abstract][Full Text] [Related]
15. Independent action of serine/threonine protein phosphatase in ovarian cancer plasma membrane and cytosol during gonadotropin-releasing hormone stimulation.
Sugiyama M; Imai A; Furui T; Tamaya T
Oncol Rep; 2003; 10(6):1885-9. PubMed ID: 14534713
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor recycling in rat hepatocytes is regulated by protein phosphatase 2A, possibly through effects on microtubule-dependent transport.
Runnegar M; Wei X; Berndt N; Hamm-Alvarez SF
Hepatology; 1997 Jul; 26(1):176-85. PubMed ID: 9214467
[TBL] [Abstract][Full Text] [Related]
17. Human tonsillar lymphocytes as targets for immunosuppressive and anticancer drugs.
Staub M; Sasvari-Szekely M; Spasokukotskaja T; Piroth Z; Kazimierczuk Z
Acta Otolaryngol Suppl; 1996; 523():124-7. PubMed ID: 9082756
[TBL] [Abstract][Full Text] [Related]
18. Analysis of DNA methylation of the 5' region of the deoxycytidine kinase gene in CCRF-CEM-sensitive and cladribine (CdA)- and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA)-resistant cells.
Leegwater PA; De Abreu RA; Albertioni F
Cancer Lett; 1998 Aug; 130(1-2):169-73. PubMed ID: 9751270
[TBL] [Abstract][Full Text] [Related]
19. Structure of human dCK suggests strategies to improve anticancer and antiviral therapy.
Sabini E; Ort S; Monnerjahn C; Konrad M; Lavie A
Nat Struct Biol; 2003 Jul; 10(7):513-9. PubMed ID: 12808445
[TBL] [Abstract][Full Text] [Related]
20. Association of protein phosphatase 2A with its substrate vimentin intermediate filaments in 9L rat brain tumor cells.
Cheng TJ; Lin YL; Chiang AS; Lai YK
J Cell Biochem; 2000 Jul; 79(1):126-38. PubMed ID: 10906761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]